
Investment Rating - The report maintains a "Buy" rating for the company [6] Core Views - In Q1 2025, the company achieved revenue of 2.2 billion yuan, a year-on-year increase of 35%, but a quarter-on-quarter decrease of 39%. The net profit attributable to the parent company was 300 million yuan, up 26% year-on-year but down 55% quarter-on-quarter. The non-recurring net profit was also 300 million yuan, reflecting a 13% year-on-year increase but a 48% quarter-on-quarter decrease [4][5] - For the year 2024, the company is projected to achieve revenue of 9.1 billion yuan, a year-on-year increase of 45%, with a net profit of 1.6 billion yuan, down 10% year-on-year, and a non-recurring net profit of 1.4 billion yuan, up 17% year-on-year [4][5] - The company invested 2.5 billion yuan in R&D in 2024, a 94% increase year-on-year, with an R&D expense ratio of 16%. The company is developing over twenty new devices, significantly accelerating the development timeline from 3-5 years to 2 years or less. This high R&D investment has resulted in substantial new order growth, as evidenced by a 162% year-on-year increase in contract liabilities to 3.1 billion yuan [5] Financial Summary - The company’s projected financials for 2025-2027 include net profits of 2.48 billion yuan, 3.41 billion yuan, and 4.29 billion yuan, respectively, with corresponding EPS of 3.96 yuan, 5.46 yuan, and 6.87 yuan. The price-to-earnings ratios (PE) are expected to be 45x, 33x, and 26x, respectively [6][8] - The company’s revenue is expected to grow from 9.07 billion yuan in 2024 to 12.12 billion yuan in 2025, reflecting a year-on-year growth rate of 33.7%. The gross margin is projected to improve from 41.1% in 2024 to 43.5% in 2025 [8]